Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis
ItalyStudy of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors
ItalyStudy of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer
ItalyStudy of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors
ItalyStudy on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer
ItalyStudy Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Inhibitor Treatment
ItalyStudy on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors
ItalyStudy on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy of Romidepsin and Drug Combination for Young Patients with Peripheral T-Cell Lymphomas Before Stem Cell Transplantation
ItalyStudy of durvalumab, carboplatin and etoposide combination therapy for patients with metastatic large-cell neuroendocrine lung cancer who have not received previous treatment
ItalyStudy of Durvalumab and Regorafenib for Patients with Stage IV Colorectal Cancer with No Evidence of Disease
ItalyStudy on the Safety and Effectiveness of EHSG-KF for Treating Full-Thickness Skin Defects in Adults and Children
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
